Group 2 ILCs: A way of enhancing immune protection against human helminths?

od Nausch, N., Mutapi, F.
izdano v Parasite Immunol (2017)

Acquired immune heterogeneity and its sources in human helminth infection

od BOURKE, C. D., MAIZELS, R. M., MUTAPI, F.
Izdano 2011

Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses

od Reilly, L, Magkrioti, C, Mduluza, T, Cavanagh, DR, Mutapi, F
Izdano 2008

Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status

od Milner, T, Reilly, L, Nausch, N, Midzi, N, Mduluza, T, Maizels, R, Mutapi, F
Izdano 2010

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies

od RUJENI, N, NAUSCH, N, MIDZI, N, MDULUZA, T, TAYLOR, D W, MUTAPI, F
Izdano 2012

Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4

od MUTAPI, F, BOURKE, C, HARCUS, Y, MIDZI, N, MDULUZA, T, TURNER, C M, BURCHMORE, R, MAIZELS, R M
Izdano 2011